- Tagged as
- - Derived product
- - Antibody or Hybridoma
- - Hybridoma
Produced by: UNIBAS
Shipping From: Basel - CH
anti-idiotype mAb: raised against VI10 antibody
Product Risk Group:
Information on the related virus
The hybridoma was produced from the fusion of Browns Norway rats with mouse myeloma cell line X63AG8.653 following immunisation with the ab VI10.
Information on characterization:
35.61 recognizes a combinatorial determinant provided by VH and VK of antibody VI10. Binding of 35.61 inhibited VSV neutralisation of VSV by VI10. The ab binds to 10-15% of B cells in mice transgenic for the VI10 heavy chain and >90% of B cells in mice transgenic for the VI10 heavy and light chain.